ASX RELEASE 30 October 2026 September 2026 Quarterly Activities Report Paradigm Biopharmaceuticals Ltd (Administrators Appointed) (ASX: PAR) (Paradigm or the Company) provides its quarterly activities report for the three months ended 30 September 2026. The quarter concluded with the Phase 3...
September 2026 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Paradigm Biopharmaceuticals Ltd. on 6ix
Story so far
Earlier from Paradigm Biopharmaceuticals
- Convening Period Extended to 27 January 2027
- Extension of Convening Period
- PPS Shows Significant Pain Benefit in Rest of World Analysis
- Continuation of Suspension from Quotation
- Appointment of Voluntary Administrators
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals